Drug Profile
BO 2367
Alternative Names: (-) BO 2367Latest Information Update: 19 May 2001
Price :
$50
*
At a glance
- Originator Banyu
- Class Antineoplastics; Quinolones
- Mechanism of Action DNA gyrase inhibitors; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 May 2001 Discontinued-Preclinical for Cancer in Japan (Unknown route)
- 23 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 28 Nov 1996 Preclinical development for Cancer in Japan (Unknown route)